Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.
But what would these various proposals accomplish, and how likely is it they’ll be signed into law?
[jwp-video n=”1″]
Recent Stories
Democratic division in the shape of Lebanon
Bipartisan AI draft proposes three-year preemption of state laws
Capitol Lens | Where’s Mulder?
Immigration budget bill off to a slow start in Senate
At the Races: Tricks of the trade
Trump backs Senate’s version of college athletics bill